Cargando…

Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France

BACKGROUND: Several studies have investigated the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal (Sp) and staphylococcal (Sa) nasopharyngeal (NP) carriage. Few have investigated the impact on Haemophilus influenzae (Hi) and Moraxella catarrhalis (Mc) carriage. We aimed to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Robert, Bingen, Edouard, Levy, Corinne, Thollot, Franck, Boucherat, Michel, Derkx, Véronique, Varon, Emmanuelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323894/
https://www.ncbi.nlm.nih.gov/pubmed/22397629
http://dx.doi.org/10.1186/1471-2334-12-52
_version_ 1782229271060676608
author Cohen, Robert
Bingen, Edouard
Levy, Corinne
Thollot, Franck
Boucherat, Michel
Derkx, Véronique
Varon, Emmanuelle
author_facet Cohen, Robert
Bingen, Edouard
Levy, Corinne
Thollot, Franck
Boucherat, Michel
Derkx, Véronique
Varon, Emmanuelle
author_sort Cohen, Robert
collection PubMed
description BACKGROUND: Several studies have investigated the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal (Sp) and staphylococcal (Sa) nasopharyngeal (NP) carriage. Few have investigated the impact on Haemophilus influenzae (Hi) and Moraxella catarrhalis (Mc) carriage. We aimed to compare the NP carriage rates in young children with acute otitis media (AOM) before and after PCV7 implementation in France. METHODS: Prior to PCV7 implementation, we performed 4 successive randomized trials with NP samples. These studies compared several antibiotic regimens for treating AOM in young children (6 to 30 months). After PCV7 implementation, to assess the impact of the vaccination program on NP flora, young children with AOM were enrolled in a prospective surveillance study. In each study, we obtained an NP sample to analyze the carriage rates of Sp, Hi, Mc and Sa and the factors influencing the carriage. Standardized history and physical examination findings were recorded; the methods used for NP swabs (sampling and cultures) were the same in all studies. RESULTS: We enrolled 4,405 children (mean age 13.9 months, median 12.8). Among the 2,598 children enrolled after PCV7 implementation, 98.3% were vaccinated with PCV7. In comparing the pre- and post-PCV7 periods, we found a slight but non-significant decrease in carriage rates of pneumococcus (AOR = 0.85 [0.69;1.05]), H. influenzae (AOR = 0.89 [0.73;1.09]) and S. aureus (AOR = 0.92 [0.70;1.19]). By contrast, the carriage rate of M. catarrhalis increased slightly but not significantly between the 2 periods (AOR = 1.08 [0.95;1.2]). Among Sp carriers, the proportion of PCV7 vaccine types decreased from 66.6% to 10.7% (P < 0.001), penicillin intermediate-resistant strains increased from 30.3% to 43.4% (P < 0.001), and penicillin-resistant strains decreased greatly from 22.8% to 3.8% (P < 0.001). The proportion of Hi ß-lactamase-producing strains decreased from 38.6% to 17.1% (P < 0.001). CONCLUSION: The carriage rates of otopathogen species (Sp, Hi, Mc) and Sa did not significantly change in children with AOM after PCV7 implementation in France. However, we observed significant changes in carriage rates of PCV7 vaccine serotypes and penicillin non-susceptible Sp.
format Online
Article
Text
id pubmed-3323894
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33238942012-04-12 Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France Cohen, Robert Bingen, Edouard Levy, Corinne Thollot, Franck Boucherat, Michel Derkx, Véronique Varon, Emmanuelle BMC Infect Dis Research Article BACKGROUND: Several studies have investigated the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal (Sp) and staphylococcal (Sa) nasopharyngeal (NP) carriage. Few have investigated the impact on Haemophilus influenzae (Hi) and Moraxella catarrhalis (Mc) carriage. We aimed to compare the NP carriage rates in young children with acute otitis media (AOM) before and after PCV7 implementation in France. METHODS: Prior to PCV7 implementation, we performed 4 successive randomized trials with NP samples. These studies compared several antibiotic regimens for treating AOM in young children (6 to 30 months). After PCV7 implementation, to assess the impact of the vaccination program on NP flora, young children with AOM were enrolled in a prospective surveillance study. In each study, we obtained an NP sample to analyze the carriage rates of Sp, Hi, Mc and Sa and the factors influencing the carriage. Standardized history and physical examination findings were recorded; the methods used for NP swabs (sampling and cultures) were the same in all studies. RESULTS: We enrolled 4,405 children (mean age 13.9 months, median 12.8). Among the 2,598 children enrolled after PCV7 implementation, 98.3% were vaccinated with PCV7. In comparing the pre- and post-PCV7 periods, we found a slight but non-significant decrease in carriage rates of pneumococcus (AOR = 0.85 [0.69;1.05]), H. influenzae (AOR = 0.89 [0.73;1.09]) and S. aureus (AOR = 0.92 [0.70;1.19]). By contrast, the carriage rate of M. catarrhalis increased slightly but not significantly between the 2 periods (AOR = 1.08 [0.95;1.2]). Among Sp carriers, the proportion of PCV7 vaccine types decreased from 66.6% to 10.7% (P < 0.001), penicillin intermediate-resistant strains increased from 30.3% to 43.4% (P < 0.001), and penicillin-resistant strains decreased greatly from 22.8% to 3.8% (P < 0.001). The proportion of Hi ß-lactamase-producing strains decreased from 38.6% to 17.1% (P < 0.001). CONCLUSION: The carriage rates of otopathogen species (Sp, Hi, Mc) and Sa did not significantly change in children with AOM after PCV7 implementation in France. However, we observed significant changes in carriage rates of PCV7 vaccine serotypes and penicillin non-susceptible Sp. BioMed Central 2012-03-07 /pmc/articles/PMC3323894/ /pubmed/22397629 http://dx.doi.org/10.1186/1471-2334-12-52 Text en Copyright ©2012 Cohen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cohen, Robert
Bingen, Edouard
Levy, Corinne
Thollot, Franck
Boucherat, Michel
Derkx, Véronique
Varon, Emmanuelle
Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
title Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
title_full Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
title_fullStr Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
title_full_unstemmed Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
title_short Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France
title_sort nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in france
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323894/
https://www.ncbi.nlm.nih.gov/pubmed/22397629
http://dx.doi.org/10.1186/1471-2334-12-52
work_keys_str_mv AT cohenrobert nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance
AT bingenedouard nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance
AT levycorinne nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance
AT thollotfranck nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance
AT boucheratmichel nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance
AT derkxveronique nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance
AT varonemmanuelle nasopharyngealflorainchildrenwithacuteotitismediabeforeandafterimplementationof7valentpneumococcalconjugatevaccineinfrance